Are DEA-Waivered Buprenorphine Prescribers Co-Located With Behavioral Health Clinicians?

Medication is increasingly used to treat opioid use disorder (OUD) in primary care. It incorporates medication (ie, buprenorphine) with behavioral therapy and/or psychosocial services. Targeted planning for co-location of DEA-waivered buprenorphine prescribers and behavioral health (BH) clinicians could increase the use of MOUD. Presently, less than half of all waivered prescribers, outside of hospitals, are co-located with BH clinicians.

This article provides information on where co-location of DEA-waivered buprenorphine prescribers and BH clinicians occurs and among which type of providers. As this brief details, co-location varies geographically and by profession.
November 7, 2023

November 7, 2023


    Want to stay up to date?

    Sign up for our mailing and never miss a new piece of information.

    I would like updates for:

    Filter Results


    Filter Search Results